Literature DB >> 30784632

Classification of global measles cases in 2013-17 as due to policy or vaccination failure: a retrospective review of global surveillance data.

Minal K Patel1, Walter A Orenstein2.   

Abstract

BACKGROUND: Despite improvements in reported coverage of measles-containing vaccine (MCV) and progress towards elimination of measles, 172 939 measles cases were reported worldwide in 2017. Questions have been raised about whether measles cases are due to failure of immunisation programmes or vaccine policy failure, which might require changes to vaccination schedules or number of doses.
METHODS: This retrospective review of global surveillance data analysed case-based data for cases of measles occurring during 2013-17 submitted to WHO by its member states. Cases were classified as programmatically preventable (ie, did not receive the age-appropriate number of doses for that country) or programmatically non-preventable (ie, appropriately vaccinated as per national programme) on the basis of age at onset, year of birth, vaccination status, and eligibility for MCV doses in the country reporting the case. We grouped reasons why cases were non-preventable into four categories as follows: (1) received at least two doses of MCV; (2) too young for first dose; (3) received one dose but was too young to receive the second; or (4) was only eligible for one dose according to the national schedule. We analysed numbers and proportions of preventable and non-preventable cases of measles by region and year, reasons for non-preventable cases by year, preventable cases by age group, and preventable and non-preventable cases, including reasons for non-preventable cases, by measles elimination status of countries.
FINDINGS: Between Jan 1, 2013, and Dec 31, 2017, 634 139 measles cases were reported; 7850 (1%) cases were excluded because they did not provide age at onset, so 626 289 were included in our analysis. 191 333 (31%) of these cases had unknown vaccination status. 275 754 (63%) of the 434 956 cases with available vaccination data were categorised as programmatically preventable, 213 461 (77%) of whom were aged 1 year to less than 15 years. 156 384 (36%) cases were categorised as non-preventable, of whom 38 677 (25%) were two-dose vaccine recipients, 74 438 (48%) were too young to receive their first MCV dose, 11 914 (8%) received their first dose and were too young to receive their second dose, and 31 355 (20%), mostly in the Africa region, were non-preventable because they were only eligible for one dose on the basis of the national immunisation programme.
INTERPRETATION: Most measles cases during 2013-17 were programmatically preventable, highlighting the need for improving the effectiveness of immunisation programmes that already exist. Individual countries should do similar analyses to establish the changes needed in their country to decrease numbers of measles cases. FUNDING: None.
© 2019 World Health Organization; licensee Elsevier. This is an Open Access article published under the CC BY NC ND 3.0 IGO license which permits users to download and share the article for non-commercial purposes, so long as the article is reproduced in the whole without changes, and provided the original source is properly cited. This article shall not be used or reproduced in association with the promotion of commercial products, services or any entity. There should be no suggestion that WHO endorses any specific organisation, products or services. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30784632     DOI: 10.1016/S2214-109X(18)30492-3

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN: 2214-109X            Impact factor:   26.763


  11 in total

Review 1.  Measles, the need for a paradigm shift.

Authors:  Emilie Javelle; Philippe Colson; Philippe Parola; Didier Raoult
Journal:  Eur J Epidemiol       Date:  2019-10-17       Impact factor: 8.082

2.  Measles vaccine immune escape: Should we be concerned?

Authors:  Luojun Yang; Bryan T Grenfell; Michael J Mina
Journal:  Eur J Epidemiol       Date:  2019-11-01       Impact factor: 8.082

3.  Molecular Epidemiology of B3 and D8 Measles Viruses through Hemagglutinin Phylogenetic History.

Authors:  Silvia Bianchi; Marta Canuti; Giulia Ciceri; Maria Gori; Daniela Colzani; Marco Dura; Beatrice Marina Pennati; Melissa Baggieri; Fabio Magurano; Elisabetta Tanzi; Antonella Amendola
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

4.  The effects of switching from 10 to 5-dose vials of MR vaccine on vaccination coverage and wastage: A mixed-method study in Zambia.

Authors:  Kirstin Krudwig; Barbara Knittel; Ali Karim; Natasha Kanagat; Wendy Prosser; Guissimon Phiri; Frances Mwansa; Robert Steinglass
Journal:  Vaccine       Date:  2020-07-21       Impact factor: 3.641

5.  Measles and rubella immunity in the population of Bhutan, 2017.

Authors:  Sonam Wangchuk; Francisco Nogareda; Namgay Tshering; Lekey Khandu; Sonam Pelden; Kathleen Wannemuehler; Sonam Wangdi; Ugyen Wangchuk; Mick Mulders; Tshewang Tamang; Minal K Patel
Journal:  Vaccine       Date:  2019-09-06       Impact factor: 3.641

6.  Measles Vaccine-Associated Rash Illness in China: an Emerging Issue in the Process of Measles Elimination.

Authors:  Aili Cui; Huiling Wang; Zhen Zhu; Naiying Mao; Jinhua Song; Yan Zhang; Wenbo Xu
Journal:  J Clin Microbiol       Date:  2020-10-21       Impact factor: 5.948

7.  Inhibition of Measles Viral Fusion Is Enhanced by Targeting Multiple Domains of the Fusion Protein.

Authors:  Francesca T Bovier; Ksenia Rybkina; Sudipta Biswas; Olivia Harder; Tara C Marcink; Stefan Niewiesk; Anne Moscona; Christopher A Alabi; Matteo Porotto
Journal:  ACS Nano       Date:  2021-07-22       Impact factor: 18.027

8.  Effect of measles vaccination in infants younger than 9 months on the immune response to subsequent measles vaccine doses: a systematic review and meta-analysis.

Authors:  Laura M Nic Lochlainn; Brechje de Gier; Nicoline van der Maas; Rob van Binnendijk; Peter M Strebel; Tracey Goodman; Hester E de Melker; William J Moss; Susan J M Hahné
Journal:  Lancet Infect Dis       Date:  2019-09-20       Impact factor: 25.071

9.  Measles and mumps outbreaks in Lebanon: trends and links.

Authors:  Talal El Zarif; Mohamed Faisal Kassir; Nazih Bizri; Ghida Kassir; Umayya Musharrafieh; Abdul Rahman Bizri
Journal:  BMC Infect Dis       Date:  2020-03-26       Impact factor: 3.090

Review 10.  A Narrative Review of COVID-19 Vaccines.

Authors:  Barbaros Eroglu; Rina Fajri Nuwarda; Iqbal Ramzan; Veysel Kayser
Journal:  Vaccines (Basel)       Date:  2021-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.